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A B S T R A C T
In Pennsylvania, cancer patients experience disparate cancer-related health outcomes. Patient navigation, a
patient-centered evidence-based approach effectively addresses barriers to care, and reduces cancer-related
disparities and burden. We performed a literature search with specific inclusion and exclusion criteria to identify
literature emanating from the United States which potentially described the development, efficacy and cost
effectiveness of patient navigation across the United States and in Pennsylvania. The results from this review
signified that, over last two decades there has been a rapid growth in the field of patient navigation programs
across the United States which includes the state of Pennsylvania. However, despite the presence of these
programs and navigators, Pennsylvania does not have state-wide guidelines which could define patient navi-
gation and recognizes a patient navigators as well as roles and responsibilities. This paper calls for a policy-based
approach to recognize and standardize patient navigation in Pennsylvania. We recommend the Pennsylvania
Department of Health propose legislation which would help define patient navigation and patient navigator. We
also urge various organizations, policy makers, state and private insurers, and funding agencies in Pennsylvania
to recognize, acquire, and cultivate a culture of patient-centeredness through patient navigation.
1. Background
Despite cancer mortality decreasing by 29% from 1991 to 2017,
cancer still remains the second most common cause of death in the
United States (US), exceeded only by heart disease [1]. According to the
American Cancer Society (ACS), more than 1.8 million new cancer
cases are expected to be diagnosed in the US during 2020 [2]. In 2020
alone, approximately 606,520 US residents will die from cancer, which
translates to about 1660 deaths per day [2]. Pennsylvania has the third
highest cancer incidence rate nationally, and the second highest among
states in the Northeast [3]. In 2020, Pennsylvania is estimated to have
approximately 80,240 new cases and 27,860 deaths [2]. The medical
costs and lost productivity from cancer in Pennsylvania are estimated to
be $7.3 billion each year [4]. Over the last two decades there has been
significant advances in cancer screening and treatment which has re-
sulted in overall reduction in morbidity and mortality among those
diagnosed with cancer. However, there still exists disparities in re-
ceiving this recommended screening, care, and treatment [1,5–8].
1.1. Cancer-related disparities
Although there are significant medical and technological advance-
ments afforded by the American healthcare system, the fractured in-
frastructure can make it difficult for patients to access and manage their
care and treatment [9]. As per the National Cancer Institute (NCI),
cancer disparities are thought to reflect the interplay of social, eco-
nomic, cultural, environmental, diet, biological, and health system
factors [8]. While the reasons for these cancer-related disparities are
complex and not completely understood, research has identified nu-
merous patient, provider, and health system barriers for these at-risk
populations [10,11]. Across the US, these barriers include low health
literacy, delays in early diagnosis and treatment, access to services,
transportation, inadequate health insurance, and other structural, and
personal obstacles to health care [2,6]. In Pennsylvania, residents of the
52 Appalachian counties experience excess cancer burden due to
transportation and financial barriers, as well as limited availability of
certified cancer screening facilities, oncologists and primary care pro-
viders [12]. There has also been an growing body of evidence which
indicates that cancer-related barriers interfere with timely access to
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diagnosis and treatment and could possibly lead to negative health
outcomes [6,13]. Hence, in recent years, reducing cancer disparities has
become an overarching goal of policy-makers and researchers.
1.2. Patient navigation
Patient navigation (PN) has been demonstrated to be an effective
and scalable intervention model to overcome these disparities and
barriers [6,7,13–16]. Dr. Harold Freeman, a pioneer in PN, defined PN
as, “a community-based service delivery intervention designed to promote
access to timely diagnosis and treatment of cancer and other chronic diseases
by eliminating barriers to care” [17]. People who practice PN, are known
by various names, including, but not limited to, patient navigator, nurse
navigator, social worker, outreach worker, community health worker
(CHW), and promotora (Spanish term for “CHW”). Patient navigators
play an important role in addressing these challenges by educating
people about cancer prevention and screening, connecting patients to
healthcare providers, providing linkages to financial and community
resources, and navigating patients through the healthcare system [9].
Over last two decades, there has been a rapid growth of patient
navigation programs across the US [14]. However, despite the presence
of these programs and navigators, there are many states in the US which
do not have state-wide guidelines that define patient navigation and
recognize patient navigators and their roles and responsibilities. De-
spite the presence of several PN programs, Pennsylvania lacks statewide
PN guidelines. The objective of this paper is to address this gap, de-
scribe the existing literature on PN research and programs across the US
and specifically in the state of Pennsylvania, and call for a policy-based
approach to recognize and standardize PN in Pennsylvania. We re-
commend the PA Department of Health propose a legislation which
would help define PN and patient navigator. Finally, we also urge
various organizations, policy makers, state and private insurers, and
funding agencies in PA to recognize, acquire, and cultivate a culture of
patient-centeredness through patient navigation.
2. Methods
There have been several authors who have conducted full literature
reviews of PN research and implementation programs across the US.
The primary focus of the current paper is, however, not to conduct a
literature review on PN research and programs. We aim to highlight the
development of PN programs across US and more particularly in
Pennsylvania so that, based on this available evidence appropriate
policy recommendations for the state of Pennsylvania could be sug-
gested. As part of the methodology, this paper followed a two-step mini-
literature review process. In the first step, on-line resources such as
PubMed, Google Scholar, and Penn State Library Resources were sear-
ched to find appropriate US based peer-reviewed literature with a
limitation to English language. Searches were conducted using combi-
nations of the following key words: “patient navigation”, “Cancer”,
“policy”, “patient navigator” and “health disparities”. Previously iden-
tified key publications relevant and suited to the inclusion criteria were
also used in the literature review.
In the second stage, we screened all identified references and ca-
tegorized them in separate groups such as development of PN funding
across the US, efficacy of PN, socioeconomic benefits of PN, and PN
programs or studies conducted in Pennsylvania. Both qualitative and
quantitative research were considered for this paper. The literature was
restricted to the last three decades to stay current with government
policy and studies on cancer PN. The literature selected included cross-
sectional studies, randomized control trials, systematic reviews, brief
reports, news articles, published program evaluations, policy briefs, and
government and non-government organizations reports.
3. Results
3.1. Rise of patient navigation research & programs across the United States
Since 1990, PN has been a model of care that expanded rapidly in
underserved communities and medical institutions across the US
[13,14]. The National Cancer Institute’s (NCI) 2003 survey reported
more than 200 cancer care programs across the US which provided
some form of PN to cancer patients [18]. The first substantial research
grant for PN came in the year 2005, when NCI along with the ACS
provided $25 million to 9 sites in the Patient Navigation Research
Program (PNRP) initiative [19]. The purpose of this initiative was to
evaluate the efficacy and cost-effectiveness of cancer-related PN [19].
Further, the federal legislative and executive agencies were also in-
volved in the advancement of cancer-related PN across the US [20]. The
Patient Navigator and Chronic Disease Prevention Act of 2005 further
resulted in $2.4 million grant from the Health Resources and Services
Administration (HRSA) [20]. Six two-year demonstration programs
were funded by the Health Resources and Services Administration
(HRSA) in 2008 to support lay patient navigators who provide services
that focused on a wide variety of health conditions (e.g., cancer, heart
disease, diabetes, hypertension, obesity, asthma) [13,14]. By 2010, the
number of PN demonstration projects funded by HRSA increased to ten
[14].
Further, through their National Breast and Cervical Cancer Early
Detection Program (NBCCEDP), the Centers for Disease Control and
Prevention (CDC) provides PN services to overcome the barriers and
help low-income, uninsured, and underinsured women gain access to
timely breast and cervical cancer screening, diagnostic, and treatment
services [21]. Currently, the NBCCEDP funds 70 grantees–all 50 states,
the District of Columbia, 6 US territories, and 13 American Indian/
Alaska Native tribes or tribal organizations [21]. Also, until 2018, the
ACS had funded more than 80 patient navigation programs across the
United States [22]. The increase in PN programs and research was di-
rectly related to the federal and private foundation funding [18]. Sev-
eral studies across the US including Pennsylvania have described the
efficacy of PN, and its cost effectiveness; we have summarized a few
below to provide evidence for PN programs across the US and parti-
cularly in Pennsylvania.
3.2. Efficacy of patient navigation
Year after year this rising trend of PN programs across the US have
benefited thousands of cancer patients. PN has shown to be effective in
screening, diagnostic resolution, treatment and clinical trial enrollment
[13,14,23].
3.2.1. Screening
The comprehensive Breast and Cervical Cancer Control Navigation
Program (BCCCNP) of the Michigan Department of Health and Human
Services (MDHHS) alone has provided breast and cervical cancer
screenings to more than 656,439 women and diagnosed 4873 breast
cancers and 6453 cervical cancers [24]. Since 2015, approximately
173,000 people across the US have relied on the PN program to help
them through screening, diagnosis and treatment [2,25–27]. These PN
programs were delivered by patient navigators from several educational
backgrounds towards an increase in screening and early detection of
cancer [13,14].Two systematic reviews have reported that PN im-
proved cancer screening rates in the range of 10.8%–17.1% for three
major cancers namely breast, cervical and colorectal [13,14]. Besides,
adherence to follow up visits following a screening abnormality have
been reported to increase in the range of 21%–29.2% [13,14]. The
evaluation of PNRP revealed that. PN increased rates of resolution of
abnormal cancer screening findings and decreased the time it typically
takes patients to receive a diagnostic resolution [28]. The rates of
treatment initiation were also increased among patients who typically
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failed to begin treatment within 90 days of a cancer diagnosis [28]. In
Texas, a three-year community-based PN program reported increased
uptake and adherence for cervical cancer screening among Hispanic
women resulting in a per capita gain of 0.2 years of life expectancy
[29].
3.2.2. Diagnostic resolution
A randomized control trial conducted among racially/ethnically
diverse inner city population in Boston, showed a significant decrease
in time to diagnosis for subjects in the navigated group with a cervical
and breast cancer screening abnormality [30]. The systematic review
on efficacy of PN revealed that more than 25 articles focused on the
effect of PN on the diagnostic resolution or timely follow‐up of an ab-
normal test result and reported a favourable impact of PN interventions
on diagnostic resolution in comparison with usual care [23]. These
studies showed that compared with patients receiving usual care, pa-
tients in the PN group experienced a shorter length of time to follow‐up
and higher rates of completion of appropriate follow‐up/attendance to
scheduled appointments. Further, several systematic reviews have also
covered other studies which were focused on medically underserved
areas, uninsured populations, or rural Appalachian populations and
overall even these studies suggested that PN was effective in increasing
rates of diagnostic resolution consistently across diverse populations
[13,14,23].
3.2.3. Treatment and patient satisfaction
Studies have also reported positive impact on cancer treatment,
including a shorter time to treatment initiation, higher rates of treat-
ment reception or adherence and increased patient satisfaction with
cancer care [13,14,23]. PN can also contribute to enhanced relation-
ships between patients and the health care team and may help increase
patient satisfaction by reducing barriers and promoting patient-cen-
teredness in the care process [31]. A qualitative study while high-
lighting the experiences of various patients through the cases presented
found that, patient navigators tailored navigation strategies to guide
each patient and aid them in overcoming the oftentimes fragmented,
complex, or confusing system of care [32]. These tailored strategies
ranged from researching affordable housing, transportation, and pre-
scription options to helping patients apply for health insurance and
developing critical bonds with local health clinics and community or-
ganizations to improve patients’ access to resources· Additionally, PN
has also been seen effective in improving the underrepresentation of
racial and ethnic minorities in clinical trials [23,33]. PN increased
enrollment into clinical studies in a county hospital setting serving
minority and underserved population [34]. Other studies found that PN
interventions resulted in higher rates of attendance to medical ap-
pointments, lower rates of hospitalization, and fewer intensive care unit
admissions and emergency room visits [35].
3.3. Cost effectiveness of patient navigation
Apart from the early screening and treatment benefits, PN can also
be an effective business strategy for cancer care. PN has the potential to
increase top-line revenue in a fee-for-service (FFS) payment system and
decrease costs in a bundled payment system [35]. Scientific literature
clearly demonstrates a positive return on investment (ROI) for patients
in a PN program in an alternative payment model systems, as well as in
health systems operating in a FFS environment [35]. The University of
Alabama study on cost effectiveness found that PN yielded a 1:10 ROI,
with average costs for patients receiving PN declining by $781.29 per
patient per quarter and saving of $19 million annually across the net-
work [35]. Another study conducted at Michigan’s Grand River Gas-
troenterology Institute identified that, only addressing the transporta-
tion barrier with the help of PN, the colonoscopy cancellation rate
decreased by 54% and yielded an estimated annual saving of $168,152
[36]. The Levine Cancer Institute (LCI), based in Charlotte, NC,
reported that for each disease subset, except melanoma, patients in the
PN program had a reduction in health care usage in the acute care
setting (P < .001) [35]. Another study reported 52% increased like-
lihood of a 30-day all-cause readmission among the patients who did
not receive PN services (P= .04) [35].
Improved patient-related outcomes such as patient satisfaction,
patient perceptions of PN, timeliness of care, care quality, adherence to
screening, appointments, treatments and quality of life are also found to
be cost-effective and contribute towards net financial gains [19,35,37].
One such example is Sarah Cannon, the Cancer Institute of HCA
Healthcare which had a PN program that supported 65 hospitals across
seven states [35]. These hospitals provided PN to more than 15,000
patients in 2018 and within a year, 59% growth in patient enrollment to
PN program was observed, correlating with increased patient volumes.
Additionally, another important quality measure at these hospitals was
time from first diagnosis to first treatment, where the goal of less than
30 days was met across all disease sites. Another program at three
hospitals in New York reported PN to be associated with a 61% increase
in average monthly colonoscopy volume yielding a net financial benefit
to the hospitals [38].
PN programs also significantly reduced medical treatment costs and
potentially provided cost savings to the health care payer [39]. An
economic evaluation of PN conducted at 3 community hospitals re-
vealed that, PN helped in achieving a cancer diagnostic resolution
which eventually resulted in decreased medical costs by $511 to $2080
per patient with breast cancer and by $1192 to $9708 per patient with
colorectal cancer [40]. The average cost savings ranged from $528 to
$781 per quarter per patient [39]. A pilot program at Northern Cali-
fornia Healthcare Organization found that 35% fewer patients were lost
to other health systems if they were in the PN program from the point of
a suspicious cancer finding [35]. Lastly, PN programs reduced future
incident cancer diagnoses and improved timely diagnostic resolution,
and substantial future cost savings could be projected [41].
3.4. Cancer-related patient navigation programs and services in
Pennsylvania
The Penn State Cancer Institute (PSCI) has been actively involved in
training of patient navigators. They have trained more than 80 patient
navigators across Pennsylvania [42]. In July 2017, the PSCI developed
the Cancer Navigation and Survivorship Network (CaNSuN) to increase
engagement among the community of navigators throughout Pennsyl-
vania [42].The purpose of this network is to create a platform for re-
search, help disseminate best navigation practices, increase the
knowledge base of navigation methods, develop a local network among
navigators, and provide community support to navigators [42]. The
PSCI also launched a Story Map, The Story of Cancer in Central Penn-
sylvania in 2018 [43]. This highly interactive educational tool can be
viewed by individuals interested in learning more about the disease and
how navigation can help patients overcome barriers to care. This data
storytelling technology communicates important information to pa-
tients, navigators, and key stakeholders, while effectively aiding in the
broader implementation of ground-breaking health care initiatives and
research.
In addition, a group of investigators at Penn State College of
Medicine has conducted a randomized study (n=60) to test the fea-
sibility of PN to overcome barriers to cancer-related care, for women
with dense breast tissue. Women found to have dense breast tissue on a
screening mammogram have 2–6 times increased risk of developing
breast cancer. The study examined two questions: (1) whether a 12-
week telephone-based navigation for women with dense breast tissue
improves knowledge, attitude, and behaviours related to dense breast
tissue, compared to usual care; and (2) if navigation changes the rate at
which women receive supplemental breast cancer screening, compared
to usual care. The study results suggest that PN is a feasible option to
improve knowledge, attitude, and behaviours for women with dense
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breast tissue, and that the navigation helped resolve the barriers that
participants report; however, not every participant indicated that they
had barriers to address.
At Penn Medicine, a retrospective and observational study
(n=13,241) conducted at three of their Health System hospitals re-
ported that patients assisted by PN (22%, n=2996) across all cancer
types were 10% more likely to stay for treatment compared with those
not in the PN program [35]. Further, the PN supported patients also
reported an increased utilization of treatment services. Another study
(n=125) at Penn Medicine conducted to determine the feasibility,
acceptability and use of the PN program reported that, 46 patients who
completed PN-supported colonoscopy screening had at least one ade-
nomatous (precancerous) polyp and of them 3 patients were later di-
agnosed with cancer [44]. Further, when the study evaluated the pro-
gram satisfaction levels, overall 92% of the patients in this study were
highly satisfied with the program and 36% of the patients who com-
pleted the program stated they would have been, “highly unlikely to
have completed the colonoscopy without the patient navigator” [44].
In Western Pennsylvania, PN pilot programs in three hospitals found
a 43% reduction in non-emergent emergency department use among
frequent users [45]. In addition, the hospitals also showed 60% re-
duction in 30 days readmission across target diagnosis-related groups
resulting in reduced financial penalties for readmissions. Given the
costs associated with acute care and penalties for excess 30-day read-
missions under the Centers for Medicare & Medicaid Services (CMS)
Hospital Readmissions Reduction Program, these results indicate that,
engaging navigators may help reduce hospital costs [35]. Also, Ac-
centure in collaboration with Highmark Foundation has developed lay
PN pilot programs in three Western Pennsylvania hospitals, targeting
priority areas and patient populations based on the health needs of the
communities [45]. PN is also a part of the University of Pittsburgh
Medical Center (UPMC) and aims to provide individualized assistance
to the patients, families, and caregivers throughout the health care
experience [46]. The Fox Chase Cancer Center, Philadelphia, also re-
ceives funding from National Breast Cancer Foundation for its PN
program [47]. This program provides cancer education, screening and
outreach services to the community, with a special focus on reaching
underserved populations [47]. In another project, Pennsylvania’s
Healthy Woman Program trained and paid for two navigators to help
immigrant patients (n=138) over a 4-month period [48]. Among
them, 88 were screened by the Healthy Woman Program and 40 made
appointments on dates even after the project ended.
4. Discussion
4.1. Policy-based approach to cancer-related patient navigation in
Pennsylvania
The scientific literature supports the effectiveness of PN in addres-
sing cancer burden and disparities. However, despite the enormous
evidence supporting PN across the US, including the state of
Pennsylvania, there are no state-wide guidelines in Pennsylvania which
defines PN and recognizes the patient navigator and their roles and
responsibilities. Additionally, PN is not a consistently recognized pro-
fession in Pennsylvania and hence individuals with various back-
grounds fill the navigator roles. Although individuals who practice PN
may possess different sets of skills, training, and education, however,
each one has valuable expertise to offer patients. Furthermore, given
this heterogeneity in the background and role of the patient navigator,
it becomes all the more difficult to identify guidelines applicable to
various situations and individuals [49].This identity crisis of the patient
navigator in Pennsylvania could possibly be addressed through their
formal recognition within our healthcare system. The policy for re-
cognizing the work of patient navigators in Pennsylvania could further
enhance their work and contribute towards bridging the gap between
patients and the complex cancer-care system. This need for recognition
of patient navigators across all the states in the US has also been en-
dorsed under the Patient Protection and Affordable Care Act (ACA),
Public Law 111−148. The law recommends strengthening the role and
formal recognition of patient navigators in the health care system of
every state [49,50].
Apart from the recognition there are concerns over insurance re-
imbursement of patient navigators. Despite of a growing body of evi-
dence from the US which supports the financial benefits of navigators to
health systems including insurance companies, Medicare and many
commercial insurance companies do not directly pay for PN services
[35]. In fact, according to the Pennsylvania Department of Health, the
state and private insurance companies in Pennsylvania may be over-
spending on cancer treatment and rehabilitation [4]. If insurance pro-
viders cover the reimbursement for accessing PN among cancer pa-
tients, it could potentially in return receive benefits in reducing future
treatment costs through increased screening uptake and early detection
and treatment. In addition, this PN policy on formal recognition of
patient navigators in Pennsylvania could potentially encourage hospi-
tals and organizations to recruit a navigator work force to serve pa-
tients. This initiative could not only benefit patients, but could also
provide a positive return of investment to the hospitals through in-
creased screening rates and reductions in emergency and recurrent
admissions costs [31,35,36,38,39,45]. This benefit has also been voiced
by the ACA which recommends every state health insurance exchange
to establish a “navigator program” to help individuals and insurance
businesses [49]. After reviewing the literature on PN across the US and
also more particularly in Pennsylvania, we recommend the following
policy solutions for the continuum of cancer care in Pennsylvania.
4.2. Policy recommendations
This paper urges the Pennsylvania Department of Health, various
health organizations, policy makers, state and private insurers, and
funding agencies in Pennsylvania to recognize, acquire, and cultivate a
culture of patient-centeredness through patient navigation. If each were
to support in their respective capacity, Pennsylvania could benefit from
the following policy recommendations.
• The Pennsylvania Department of Health is recommended to propose
state legislation to define the term ‘PN’ & ‘Patient Navigator’ based
on the definition provided under the Patient Navigator Outreach &
Chronic Disease Prevention Act of 2005, 109, P.L. 18, 119 Stat. 340
[51]. It is also recommended to follow the same statute and enlist
the duties performed by them and help patient navigators gain the
essential recognition in the existing state’s health care workforce
and state’s human health services. Once the standard criteria is
formulated and the recognition has been established, licensure may
be the next step.
• We urge state and private insurers to provide direct reimbursement
for PN services and include it as an integral part of the health in-
surance programs.
• At an organizational level, we recommended that employers and
funders recognize patient navigators’ contribution to the public
health and healthcare infrastructure by compensating them at
competitive wage levels. Navigators should also be provided em-
ployee benefits comparable to those received by other health pro-
fessionals. Employers are also recommended to support PN career
development and formation of state and local patient navigators’
networks and associations for purposes of mutual support, ad-
vocacy, and professional development.
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